All Stories

  1. Epidemiologic & laboratory surveillance for H5N1 influenza within a large, national health system.
  2. Health Care Costs Associated With Norovirus at the Veterans Health Administration
  3. Shigella Infections in the United States Veterans Health Administration
  4. RSV Genomic Characterization
  5. P-2327. West Nile Virus Disease in the Veterans Health Administration (VHA), 2010-2023
  6. P-2328. Influenza and RSV Surveillance in the US Veterans Health Administration (VHA): 2023-2024 Season
  7. RSV Vaccine Effectiveness
  8. Risk Factors for Extrapulmonary Tuberculosis Among US Veterans, 1990–2022
  9. Clinically Defined Lymphogranuloma Venereum among US Veterans with Human Immunodeficiency Virus, 2016–2023
  10. Mpox in the Veterans Health Administration
  11. 898. Influenza Surveillance in the US Veterans Health Administration (VHA): 2022-2023 Season
  12. 1992. Two Decades of Lyme Disease in the U.S. Veterans Health Administration Detected Via Automated Surveillance Methodology, October 1999 - September 2022
  13. 899. Epidemiology of the 2022 Mpox Outbreak in the US Veterans Health Administration (VHA)
  14. 1797. Pneumococcal Vaccination in Veterans 65 years and older with Pneumococcus in the Veterans Health Administration (VHA) since November 2021
  15. Norovirus hospitalizations and mortality in Veterans Health Administration
  16. Coccidioidomycosis (Valley Fever) in the Veterans Health Administration
  17. Trends in Follow-up Testing Among Patients Positive for Chlamydia and Gonorrhea in the Veterans Health Administration, 2013 to 2019
  18. 2220. Trends in Follow-up Testing among Patients Positive for Chlamydia and Gonorrhea in the Veterans Health Administration (VHA), 2013-2019
  19. 1967. Receipt of Influenza Vaccination as Predictor of COVID-19 Vaccination among United States Veterans
  20. Exposure Sources Among Veterans With Elevated Blood Lead Levels, United States, 2015‒2021
  21. Risk Factors for Acute Gastroenteritis Among Patients Hospitalized in 5 Veterans Affairs Medical Centers, 2016–2019
  22. Association of Secretor Status and Recent Norovirus Infection With Gut Microbiome Diversity Metrics in a Veterans Affairs Population
  23. Public health surveillance in the U.S. Department of Veterans Affairs: evaluation of the Praedico surveillance system
  24. Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021
  25. 1201. Diphtheria in Veterans Health Administration (VHA), 2000-2021
  26. 227. Epidemiology of bloodstream infections in Veterans Health Administration, 2010-2020
  27. 1444. Influenza Surveillance in the Veterans Health Administration (VHA): 2020-2021 Season
  28. 702. Risk Factors for Acute Gastroenteritis Among Patients Hospitalized in 5 Veterans Affairs Medical Centers, 2016–19
  29. 98. COVID-19 Vaccine Breakthrough Hospitalizations and Deaths in the Veterans Health Administration
  30. Adapting the Surveillance Platform for Enteric and Respiratory Infectious Organisms at United States Veterans Affairs Medical Centers (SUPERNOVA) for COVID-19 Among Hospitalized Adults: Surveillance Protocol
  31. Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalization — Five Veterans Affairs Medical Centers, United States, February 1–August 6, 2021
  32. Respiratory co-infections with COVID-19 in the Veterans Health Administration, 2020
  33. COVID-19–Related Hospitalization Rates and Severe Outcomes Among Veterans From 5 Veterans Affairs Medical Centers: Hospital-Based Surveillance Study
  34. COVID-19 Infections Among Healthcare Personnel in the United States Veterans Health Administration, March to August, 2020
  35. Risk for In-Hospital Complications Associated with COVID-19 and Influenza — Veterans Health Administration, United States, October 1, 2018–May 31, 2020
  36. 1534. Gonorrhea Testing and Ceftriaxone Resistance in the Department of Veterans Affairs (VA), 2010-2019
  37. 1709. Influenza Surveillance in the U.S. Department of Veterans Affairs (VA): 2019-2020 Season
  38. Candida auris in the US Department of Veterans’ Affairs (VA)
  39. Prevalence of Drug-Resistant Mycobacterium tuberculosis in the Veterans Health Administration (VHA)
  40. Lessons Learned From a Decade of Dental Lookback Investigations in the Department of Veterans’ Affairs (VA): 2009–2019
  41. Lack of Evidence of Transmission of Bloodborne Viruses by Improperly Reprocessed Fiberoptic Endoscopes
  42. 1718. Respiratory Syncytial Virus (RSV) Surveillance in the Department of Veterans Affairs (VA), 2010-2018
  43. 397. Respiratory Coinfections with COVID-19 in Veterans Health Administration (VA), 2020
  44. COVID-19–Related Hospitalization Rates and Severe Outcomes Among Veterans From 5 Veterans Affairs Medical Centers: Hospital-Based Surveillance Study (Preprint)
  45. Incidence, Etiology, and Severity of Acute Gastroenteritis Among Prospectively Enrolled Patients in 4 Veterans Affairs Hospitals and Outpatient Centers, 2016–2018
  46. Validation of Acute Gastroenteritis-related International Classification of Diseases, Clinical Modification Codes in Pediatric and Adult US Populations
  47. 1640. Pertussis Testing in the Department of Veterans Affairs, 2010–2018
  48. 1882. Tuberculosis in the Department of Veterans Affairs: Missed Opportunities for Prevention
  49. 2313. Influenza and Respiratory Syncytial Virus (RSV) Surveillance in the US Department of Veterans Affairs (VA): 2018–2019 Season
  50. 2322. Etiology, Severity of Illness, and Risk Factors for Patients Hospitalized with Acute Gastroenteritis from Multi-Site Veteran’s Affairs (VA) Surveillance, 2016–2018: Results from SUPERNOVA
  51. Acute Hepatitis A Infection and Vaccination in the Veterans Health Administration
  52. Acute Hepatitis A Infections among Veterans in Outbreak States, 2016-2018
  53. Trends in Incidence of Norovirus-associated Acute Gastroenteritis in 4 Veterans Affairs Medical Center Populations in the United States, 2011–2015
  54. Carbon monoxide poisoning surveillance in the Veterans Health Administration, 2010–2017
  55. 1499. Gonorrhea and Chlamydia Infections in the Department of Veterans Affairs (VA), 2013–2017
  56. 2504. Influenza Surveillance and Outbreaks in the US Department of Veterans Affairs (VA): 2017–2018 Season
  57. 1648. Incidence of Norovirus and Rotavirus From Multisite Active Surveillance in Veteran’s Affairs Hospitals, December 2016–February 2018: Results From the SUPERNOVA Network
  58. Zika virus infection in the Veterans Health Administration (VHA), 2015-2016
  59. Influenza infections among U.S. Veterans.
  60. Epidemiologic Review of Veterans Health Administration Patients with Isolation of Nontuberculous Mycobacteria after Cardiopulmonary Bypass Procedures
  61. Enhanced Influenza Surveillance Using Telephone Triage and Electronic Syndromic Surveillance in the Department of Veterans Affairs, 2011-2015
  62. Firearm Injury Encounters in the Veterans Health Administration (VHA), 2010-2015
  63. Carbon Monoxide Poisoning in the Veterans Health Administration, 2010 - 2016
  64. Dengue, Chikungunya & Zika Virus in VA Caribbean HCS, Nov. 2015-Aug. 2016
  65. Comparative Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccines among Veterans: 2015–2016 and 2016–2017 Seasons
  66. Factors for Hospitalizations and Neurologic Complications in Zika Virus Infection in the Department of Veterans Affairs (VA)
  67. Incidence of Norovirus-Associated Acute Gastroenteritis in Four Veteran’s Affairs Medical Center Populations in the United States, 2011–2015
  68. Are current screening protocols for chronic hepatitis B virus infection adequate?
  69. Chikungunya Fever Cases Identified in the Veterans Health Administration System, 2014
  70. Improving the Value Proposition of Surveillance Tools: Innovative Uses for VA ESSENCE
  71. Enhancing Biosurveillance Specificity Using PraedicoTM, A Next Generation Application
  72. Epidemiologic Review of Carbapenem-Resistant Enterobacteriaceae, Duodenoscopes, and Endoscopic Ultrasonography in the Department of Veterans Affairs
  73. Influenza Surveillance in the Department of Veterans Affairs (VA): 2015–2016 Season
  74. Zika Virus Infection in the Department of Veterans Affairs (VA)
  75. Epidemiologic Review of Department of Veterans Affairs Patients With Isolation of Non-Tuberculous Mycobacteria After Cardiopulmonary Bypass Procedures
  76. Carbapenem-Resistant Enterobacteriaceae and Antimicrobial Usage Within the Veterans Affairs Healthcare System: 2010–2014
  77. Use of Shortened Regimen for the Treatment of Latent Tuberculosis Infection in Patients of the Veterans Affairs Healthcare System, 2012–2015
  78. Acute cardiac injury events ≤30 days after laboratory-confirmed influenza virus infection among U.S. veterans, 2010–2012
  79. Reuse of Insulin Pens Among Multiple Patients at 2 Veterans Affairs Medical Centers
  80. Incidence of Medically-Attended Norovirus-Associated Acute Gastroenteritis in Four Veteran’s Affairs Medical Center Populations in the United States, 2011-2012
  81. Challenges in Surveillance for Chikungunya Virus (CHIKV) Infection
  82. Evaluation of PraedicoTM, A Next Generation Big Data Biosurveillance Application
  83. Pertussis Surveillance in Veterans Affairs Medical Centers in Western United States – 2010-2014
  84. Influenza Infection in the Department of Veterans Affairs (VA), 2014–2015
  85. Epidemiologic Review of Carbapenem-Resistant Enterobacteriaceae and Duodenoscopes in the Department of Veterans Affairs
  86. Influenza Surveillance in the Department of Veterans Affairs (VA): 2012-2013 Influenza Season
  87. 1292Incidence of norovirus-associated acute gastroenteritis in four Veteran's Affairs Medical Center populations in the United States, 2011-2012
  88. 1064Influenza Infection in the Department of Veterans Affairs (VA): 2013-2014
  89. 1690Opportunities for Improved Detection and Treatment of Latent Tuberculosis Infection Among Veterans — Western United States, January 2010–July 2013
  90. Combining Surveillance Systems: Effective Merging of U.S. Veteran and Military Health Data
  91. Does Antimicrobial Prescription Data Improve Influenza Surveillance in VA?
  92. Coverage and Timeliness of Combined Military and Veteran Surveillance Systems
  93. Enhanced Influenza Surveillance using Telephone Triage Data in the VA ESSENCE Biosurveillance System
  94. Characteristics of Veterans Accessing the Veterans Affairs Telephone Triage Who Have Depression or Suicidal Ideation: Opportunities for Intervention
  95. Localized Cluster Detection Applied to Joint and Separate Military and Veteran Subpopulations
  96. Dengue Surveillance in Veterans Affairs Healthcare Facilities, 2007–2010
  97. Concurrent outbreaks with co-infection of norovirus and Clostridium difficile in a long-term-care facility
  98. Vascular access hemorrhages contribute to deaths among hemodialysis patients
  99. Results from a Large-Scale Epidemiologic Look-Back Investigation of Improperly Reprocessed Endoscopy Equipment
  100. Comparative Assessment of Antimicrobial Usage Measures in the Department of Veterans Affairs
  101. Another type of cluster monitoring: detection of groups of anomalous patient residence locations
  102. Inpatient data: a new frontier in Veterans Affairs biosurveillance and public health monitoring from the electronic health record
  103. Hierarchical filtering of ESSENCE for routine, distributed disease monitoring by the Veterans Health Administration
  104. Outbreak of Burkholderia cepacia complex among ventilated pediatric patients linked to hospital sinks
  105. Enhanced health event detection and influenza surveillance using a joint Veterans Affairs and Department of Defense biosurveillance application
  106. A Comparison of Manual and Electronic Dengue Surveillance in Puerto Rico Veterans Affairs Facilities, 2010
  107. Correlation of Annual Precipitation with Dengue Infections in Puerto Rico Veterans Affairs Facilities, 2007-2010
  108. Development of a Standardized Process for Conducting Large-Scale Epidemiologic Lookback Investigations Following Improper Reprocessing of Reusable Medical Equipment
  109. Effective Detection of the 2009 H1N1 Influenza Pandemic in U.S. Veterans Affairs Medical Centers Using a National Electronic Biosurveillance System
  110. Cluster of necrotizing enterocolitis in a neonatal intensive care unit: New Mexico, 2007
  111. Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States
  112. Enhanced Detection of Health Events through Biosurveillance in a Joint Veterans Affairs and Department of Defense Medical Center
  113. An Examination of Attitudes, Knowledge, and Clinical Practices Among Pennsylvania Pediatricians Regarding Breastfeeding and Smoking
  114. What Do Mothers Think About Concurrent Breast-Feeding and Smoking?
  115. CTNS Mutations in African American Patients with Cystinosis
  116. Ocular Nonnephropathic Cystinosis: Clinical, Biochemical, and Molecular Correlations
  117. Pulmonary Function and High-Resolution CT Findings in Patients With an Inherited Form of Pulmonary Fibrosis, Hermansky-Pudlak Syndrome, Due to Mutations in HPS-1
  118. Mutations of CTNS Causing Intermediate Cystinosis
  119. Breakpoint Identification, Detection and Frequency of the 65-kb Deletion in the Cystinosis Gene, CTNS
  120. Identification and Detection of the Common 65-kb Deletion Breakpoint in the Nephropathic Cystinosis Gene (CTNS)